Effect of Vitamin D Therapy in Autism Spectrum Disorder

Launched by MANSOURA UNIVERSITY · Oct 25, 2022

Keywords

ClinConnect Summary

This clinical trial is investigating the effects of vitamin D therapy on children with Autism Spectrum Disorder (ASD). The researchers want to see if adding vitamin D can help improve certain immune system markers and overall development in children with ASD. The study is currently looking for participants who are between 2 and 6 years old, have delayed language skills due to ASD, and are in good health with normal weight and height.

To be eligible, children should not have taken vitamin D supplements or any drugs that affect the immune system before, and they should not have any chronic illnesses or neurological disorders. If a child joins the trial, they will be monitored to see how well vitamin D supplementation works in helping them develop better language skills and overall functioning. This study could provide important insights into new treatment options for children with ASD.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Delayed language development due to ASD.
• • 2. Good nutritional status (Normal weight and height using growth charts, no Anemia and no clinical evidence of vitamin deficiency).
• • 3. Normal hearing and vision.
• Exclusion Criteria:
• • 1. History of vitamin D supplementation, drugs modulating immune system as steroid and drug formula containing vitamin D as cod liver oil.
• • 2. Known chronic disease.
• • 3. Known neurological disorders or psychiatric disorders.
• • 4. Known autoimmune or gastrointestinal disorders.